The White House ?@WhiteHouse 2h2 hours ago
To everyone who spoke out in support of an open and free internet: Thank you. #NetNeutrality ? http://wh.gov/net-neutrality

http://www.whitehouse.gov/net-neutrality

[center]Net Neutrality
President Obama's Plan for a Free and Open Internet[/center]

<>

Good things happen when people stand up.

The FCC just voted in favor of a strong net neutrality rule to keep the Internet open and free. That happened because millions of Americans across the country didn't just care about this issue: You stood up and made your voices heard, whether by adding your names to petitions, submitting public comments, or talking with the people you know about why this matters. Read a special thank-you message from the President, then learn more about how we got to where we are today.

[center][/center]

http://www.confectionerynews.com/Ingredients/Hershey-in-non-GMO-and-no-high-fructose-corn-syrup-pledge

Hershey's Milk Chocolate and Kisses to go non-GM
By Oliver Nieburg+, 23-Feb-2015

Hershey intends to remove genetically-modified ingredients from Hershey’s Milk Chocolate and Kisses by the end of the year.
COPYRIGHT PROTECTED TEXT

https://olis.leg.state.or.us/liz/2015R1/Downloads/CommitteeMeetingDocument/47661

PAGE 36-43
TESTIMONY: Senate Committee on Health Care, State of Oregon, SB 442
February 18, 2015, 3pm

Respectfully Submitted: Jonathan B. Handley, Portland, OR

I was born in 1969. My father worked for the U.S. Government and I spent my childhood living in foreign countries, including the third world. Specifically, I was born in Singapore, then lived in Laos, Mexico, Korea, Japan, India, and the Philippines.

By my sixth birthday, I received a grand total of 5 vaccines (Oral Polio, Measles, DPT, Oral Polio, and Typhoid). I still have my shot records and would be happy to share with the committee.

In 1983, attached as Exhibit A, the 1983 immunization schedule for children by the age of 6 recommended 10 vaccines (DTP, Oral Polio, DTP, Oral Polio, DTP, MMR, DTP, Oral Polio, DTP, Oral Polio).

In 2015, attached as Exhibit B, by the age of 6, the CDC now recommends 37 vaccines for children before the age of 6. (Hep B, Hep B, Rotavirus, DTaP, Hib, PCV, IPV, Flu, Rotavirus, DTaP, Hib, PCV, IPV, Rotavirus, DTaP, Hib, PCV, IPV, Flu, MMR, Varicella, Hep A, Hep B, DTaP, Hib, PCV, Flu, Hep A, DTaP, IPV, Flu, Flu, Flu, Flu, Flu, MMR, Varicella). Because this is so confusing, I’ve attached the CDC schedule with my handwritten notes to count the total vaccines.

Interestingly, as opposed to the 37 we have, many other first world countries give far fewer vaccines to children by the age of 6: Iceland (11), Sweden (11), Singapore (13), Japan (11, and pulled the MMR vaccine due to high injury rate), Norway (13), Hong Kong (13), Belgium (18), Austria (19), Israel (11), Denmark (12), Netherlands (20). Please note that every country listed has a lower under-5 mortality rate than the U.S.

Some other facts:

1. The package insert for Merck’s MMR vaccine, the only option for parents trying to protect against measles states very clearly:

“Routine administration of DTP (diphtheria, tetanus, pertussis) and/or OPV (oral poliovirus vaccine) concurrently with measles, mumps and rubella vaccines is not recommended because there are limited data relating to the simultaneous administration of these antigens.”

Note: My children and many others receive these vaccines all at once in the United States.

<>

4. PhRMA, the lobbying arm of the vaccine industry, brags that more than 300 vaccines are in development.

“Washington, D.C. (April 20, 2012)— America’s biopharmaceutical research companies are developing nearly 300 vaccines for the prevention and treatment of a wide variety of diseases, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA). The vaccines – all either currently tested in clinical trials or under review by the Food and Drug Administration – include 170 for infectious diseases, 102 for cancers and eight for neurological disorders.”

If you amend SB 442, will parents simply have to comply with every new vaccine added to the schedule? (Companies would not be developing these vaccines if they didn’t feel there was a market for them.)

5. By tying vaccination to public education, it becomes an effective mandate, as most Oregon families have neither the time, finances, nor abilities to homeschool their children.

A mandate of a medical procedure violates the very core of medical ethics code, as clearly stated by the American Medical Association:

“The patient should make his or her own determination about treatment… Informed consent is a basic policy in both ethics and law that physicians must honor, unless the patient is unconscious or otherwise incapable of consenting and harm from failure to treat is imminent.”

<>

In the free world, parents have the final say as to what is injected in their children’s bodies without losing the right to have their children educated. Canada, the UK, Japan, Ireland, Israel, Germany, Sweden, Norway, etc., etc., etc., the list goes on of countries who leave the final right for medical decisions to the parents. In fact, the only places in the free world where that right isn’t inalienable without a loss of education are the U.S. states of West Virginia and Mississippi. And, if SB 442 is amended to remove exemptions in Oregon, then our great state will become the third. Is that really who we are?

There is no imminent threat in Oregon. We’ve had exactly one reported case of measles. Please do not succumb to the hysteria of 100 measles cases reported nationwide.

If you paid close attention, what you learned from the recent measles hysteria was that the majority of adult Americans are way behind on their vaccines, which means this notion of “herd immunity” is mythical. How can the herd be protected if 80% or more of adults haven’t had their shots?

On that note, the CDC recommended adult schedule will likely be the next target of compulsory mandates. Right now, between the ages of 19 and 65, the CDC recommends every American adult get 73 vaccines (Exhibit C).

<>

http://www.cdc.gov/vaccines/hcp/vis/vis-statements/flu-hcp-info.pdf

See "Pregnancy Registries"

CDC Whistleblower Dr. Thompson on Thimerosal and Pregnant Women
Published on Aug 27, 2014

https://www.yahoo.com/parenting/parents-of-vaccine-injured-children-speak-out-110904439577.html

Parents of Vaccine-Injured Children Speak Out
Beth Greenfield
Senior Writer
February 17, 2015

http://najms.net/wp-content/uploads/v06i03.pdf#page=34

NORTH AMERICAN JOURNAL OF MEDICINE & SCIENCE
July 2013 (Volume 6, Issue 3)

Preface to the special issue of autism

Autism spectrum disorder (ASD), the fastest-growing complex neurodevelopment disorder, continues to rise in its prevalence, now affecting up to 1 in 50 children in the USA, and averaging 1% globally, according to the latest CDC report. More children will be diagnosed with ASD this year than with AIDS, diabetes & cancer combined in the USA. ASD costs the nation $137 billion a year and this debt is expected to increase in the next decade. Hence, ASD has become a huge healthcare burden and global threat, categorized by the CDC as a national public health crisis.

ASD is characterized by social-communication impairment, and restricted, repetitive, and stereotyped patterns of behavior, which cause significant disability for those affected. With its etiology still largely unknown, and its pathophysiology poorly understood, ASD currently has no universally accepted therapy. ASD is affecting more and more families; unmet services and limited resources need to be addressed urgently. Researchers, clinicians, healthcare providers, social agencies and government need to coordinate efforts to develop more effective treatments and a satisfactory continuum of care, across the lifespan. Ultimately, a cure needs to be sought for the various subtypes of ASD that exist.

The current issue of North American Journal of Medicine and Science (NAJMS) represents a continuation of our previous two special issues on autism (NAJMS Vol. 5 Issue 3 and Vol. 4 Issue 3) published in July 2012 and July 2011, respectively. In this issue, we are honored to have another panel of expert researchers and clinicians on the frontlines of ASD research and treatment to present their newest research findings and views from different perspectives.

This issue of NAJMS consists of five original research articles, two comprehensive reviews, one case report and two commentary articles, covering topics in genetics, pathogenesis, metabolic disorder biomarkers of ASD, and a clinical study, that bring into focus our newest understanding and treatment strategies.

<>

The data presented in Dr. Mumper’s review of the medical literature, suggests that ASD may be impacted by environmental toxicants, duration of breastfeeding, gut flora composition, nutritional status, acetaminophen use, vaccine practices and use of antibiotics and/or frequency of infections. In her current general pediatric practice (Advocates for Children), she has noted a modest trend toward a lower prevalence of ASD than in her previous pediatric practice or recent prevalence estimates from the CDC.

<>

The final commentary was written by Dr. Herbert, who presents her paper entitled “Everyday Epigenetics from Molecular Intervention to Public Health and Lifestyle Medicine.” She asserts that it may well take a grass roots epigenetic/lifestyle medicine revolution to avert the worsening health trends we are facing in the setting of a progressively more toxic and endangered planet. She posits that everyday epigenetics can inform science of what is possible so that society can respond on an appropriate scale to the magnitude of the crisis we are facing.

We would like to thank all the contributors to this special issue of autism for offering their great expertise in this area, as well as all the peer reviewers for their valuable critiques, comments and precious time. We would like to thank our editorial colleagues for their dedication and collaborative team work with shared vision and spirit. With all our efforts together, we have made this important issue on advances in autism possible.

Finally, we would like to thank our family members for their continuous encouragement and support.

Xuejun Kong, MD
Editor-in-Chief, NAJMS
Department of Medicine
Beth Israel Deaconess Medical Center
Harvard Medical School

Christopher J. McDougle, MD
Guest Editor, NAJMS
Lurie Center for Autism Massachusetts General Hospital
Harvard Medical School

http://www.democraticunderground.com/?com=view_post&forum=1016&pid=100858

MUMPER STUDY

METHODS
Patient Selection
Inclusion criteria were: 1) all general pediatric patients born in 2005 or later; 2) presented for well child care prior to 2 months of birth and 3) followed until at least the age of 2 years and 2 months. Totally 294 patients qualified for the inclusion criteria and have been selected in the current research.

Data Collection
All the patients have been treated and examined utilizing the same well child procedures. The electronic records for all infants cared for in our general pediatrics practice since July 1, 2005 who visited our office from prior to 2 months of age (usually in the first 3-5 days after birth) to at least the age of 2 years and 2 months have been reviewed and examined, since the age range would provide ample opportunity to observe symptoms of autism. Their developmental milestones in the domains of gross and fine motor, speech and language, and social behaviors at each of 11 well child visits in the first 2 years of life have been recorded. The medical record is marked for any child who does not meet milestones. No new cases of autism in our general pediatric practice since it was established in 2000 have been recorded; the current research reports on the cohort born in 2005 or after. CDC prevalence disease data and other published data have been utilized in analysis of this research.

RESULTS
In the current research, there are no new cases of autism out of the 294 cases recognized and recorded, resulting in 0% prevalence of ASD. Based on the CDC background risk of autism of 1 in 50 for the cohort born around 2005 we would expect to have about 6 new cases of autism in our practice. We calculated our statistics using a Chi-squared test with 1 degree of freedom. Using the CDC autism rate of 1 in 50 reported in 2013 (but based on surveys of eight year old children), the expected rate for our 294 patients starting in 2005 would be 5.88 children with autism. Zero new cases of autism would occur by chance 1.4% of the time (p-value 0.014, significant at 0.05).

http://vec.chop.edu/service/vaccine-education-center/vaccine-schedule/history-of-vaccine-schedule.html

History of Vaccine Schedule
Reviewed by: Paul A. Offit, MD
Date: April 2013

http://www.fiercevaccines.com/story/look-late-stage-vaccine-pipeline/2010-11-11

A look at the late-stage vaccine pipeline
November 11, 2010 | By Maureen Martino

In 2009, the world market for preventive vaccines totaled $22.1 billion, up from $19.0 billion in 2008, and is expected to grow at a compound annual rate of 9.7 percent to $35 billion in 2014. That's according to Kalorama Information, which has broken out a list of notable vaccines in late-stage development. Merck, GlaxoSmithKline, Sanofi Pasteur, Pfizer and Novartis combined control 83.9 percent of the world market, with GSK being the biggest vaccine seller.

As of mid-2010, Kalorama estimates there are more than 200 pediatric vaccines and many more adult preventative vaccines in development, although most are at the earliest stages of the testing process.

<>